Robert J. Cotter (1943–2012): From Mass Spectrometer Development to the Exploration of Life Lerna UzasciAvindra Nath Commentary 15 June 2013 Pages: 1049 - 1050
More Than Two HANDs to Tango Dennis KolsonShilpa Buch COMMENTARY Open access 15 November 2013 Pages: 1051 - 1054
Biomarkers for NeuroAIDS: Recent Progress in the Field Howard S. Fox COMMENTARY 29 November 2013 Pages: 1055 - 1058
Recurrent Varicella following Steroids and Fingolimod in a Multiple Sclerosis Patient D. FerraroS. De BiasiP. Sola LETTER TO THE EDITOR 27 October 2013 Pages: 1059 - 1061
Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System Alice LaroniGiovanni NoviAntonio Uccelli PERSPECTIVE 12 April 2013 Pages: 1062 - 1076
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives Anna Maria MalfitanoChiara LaezzaMaurizio Bifulco PERSPECTIVE 01 October 2013 Pages: 1077 - 1086
Applications and Limitations of Inflammatory Biomarkers for Studies on Neurocognitive Impairment in HIV Infection Edana CassolVikas MisraDana Gabuzda PERSPECTIVE Open access 21 November 2013 Pages: 1087 - 1097
Riluzole Partially Rescues Age-Associated, but not LPS-Induced, Loss of Glutamate Transporters and Spatial Memory Holly M. BrothersIsabelle BardouGary L. Wenk BRIEF REPORT 25 May 2013 Pages: 1098 - 1105
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients Laura D. SerperoGilberto FilaciDaniela Fenoglio BRIEF REPORT Open access 07 May 2013 Pages: 1106 - 1113
Identifying Risk Factors for HIV-Associated Neurocognitive Disorders Using the International HIV Dementia Scale Sara CrossNur ÖnenBeau M. Ances BRIEF REPORT 10 October 2013 Pages: 1114 - 1122
A Concise Panel of Biomarkers Identifies Neurocognitive Functioning Changes in HIV-Infected Individuals Thomas D. MarcotteReena Deutschfor the CHARTER Group INVITED REVIEW 08 October 2013 Pages: 1123 - 1135
A Biological Perspective of CSF Lipids as Surrogate Markers for Cognitive Status in HIV Norman J. HaugheyXiaomao ZhuVeera Venkata Ratnam Bandaru INVITED REVIEW 08 November 2013 Pages: 1136 - 1146
Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV Infection Richard W. PriceJulia PetersonMagnus Gisslen INVITED REVIEW Open access 13 August 2013 Pages: 1147 - 1158
Protease Resistant Protein Cellular Isoform (PrPc) as a Biomarker: Clues into the Pathogenesis of HAND Bezawit MegraEliseo EugeninJoan W. Berman INVITED REVIEW 25 April 2013 Pages: 1159 - 1166
Oxidative Stress and the HIV-Infected Brain Proteome Lerna UzasciAvindra NathRobert Cotter INVITED REVIEW 09 March 2013 Pages: 1167 - 1180
Epigenetics, Drugs of Abuse, and the Retroviral Promoter Jasmine ShiraziSonia ShahPooja Jain INVITED REVIEW 12 November 2013 Pages: 1181 - 1196
Alterations in the Levels of Vesicular Trafficking Proteins Involved in HIV Replication in the Brains and CSF of Patients with HIV-associated Neurocognitive Disorders Jerel FieldsWilmar DumaopEliezer Masliah ORIGINAL ARTICLE 30 November 2013 Pages: 1197 - 1209
Modulation of BK Channel by MicroRNA-9 in Neurons After Exposure to HIV and Methamphetamine Erick T. TatroShannon HeflerCristian L. Achim ORIGINAL ARTICLE 19 March 2013 Pages: 1210 - 1223
Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection Adrian A. EpsteinPrabagaran NarayanasamyMichael D. Boska ORIGINAL ARTICLE Open access 24 May 2013 Pages: 1224 - 1238
Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction Rebecca Hartzell RobinsonJoseph J. MeisslerToby K. Eisenstein ORIGINAL ARTICLE 04 July 2013 Pages: 1239 - 1250
Induction of Experimental Autoimmune Encephalomyelitis With Recombinant Human Myelin Oligodendrocyte Glycoprotein in Incomplete Freund’s Adjuvant in Three Non-human Primate Species Krista G. HaanstraS. Anwar JagessarBert A. ’t Hart ORIGINAL ARTICLE Open access 03 July 2013 Pages: 1251 - 1264
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype Ewa KozelaAna JuknatZvi Vogel ORIGINAL ARTICLE 28 July 2013 Pages: 1265 - 1276
Anti-JCV Antibodies Detection and JCV DNA Levels in PBMC, Serum and Urine in a Cohort of Spanish Multiple Sclerosis Patients Treated with Natalizumab Maria Inmaculada Dominguez-MozoMarta Garcia-MontojoRoberto Alvarez-Lafuente ORIGINAL ARTICLE 25 August 2013 Pages: 1277 - 1286
Identification of Novel MicroRNA Signatures Linked to Experimental Autoimmune Myasthenia Gravis Pathogenesis: Down-Regulated miR-145 Promotes Pathogenetic Th17 Cell Response Jiao WangShuangshuang ZhengYong Zhang ORIGINAL ARTICLE 17 September 2013 Pages: 1287 - 1302
Clonal Immortalized Human Glial Cell Lines Support Varying Levels of JC Virus Infection due to Differences in Cellular Gene Expression Michael W. FerenczyKory R. JohnsonEugene O. Major ORIGINAL ARTICLE 20 September 2013 Pages: 1303 - 1319
